Ocean Endowment Partners’s Pfizer PFE Stock Holding History

Ocean Endowment Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-14,635	Closed	-$453K	–	25
2020 Q1	$453K	Sell	14,635 -4,848	-25%	-$165K	0.62%	12
2019 Q4	$724K	Buy	+19,483	New	+$694K	0.69%	19

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ocean Endowment Partners's PFE Position: Q2 2020 in Review

Ocean Endowment Partners sold out of Pfizer (PFE) in Q2 2020, closing a stake of 14,635 shares — an estimated $453K sold.

Ocean Endowment Partners first reported a position in PFE in Q4 2019 and held it in 2 quarters. The position peaked at $724K in Q4 2019. 2,442 funds tracked by Wall St. Rank hold PFE as of Q2 2020.

Ocean Endowment Partners reported no remaining Pfizer position as of Q2 2020 after selling out during the quarter.
Ocean Endowment Partners sold 14,635 Pfizer shares in Q2 2020, an estimated $453K.
Ocean Endowment Partners first reported a position in Pfizer in Q4 2019 and held it in 2 quarters.
Ocean Endowment Partners's Pfizer position peaked at $724K in Q4 2019.
2,442 funds tracked by Wall St. Rank held Pfizer as of Q2 2020.

Based on Ocean Endowment Partners's 13F filing for Q2 2020, filed 4 Aug 2020.